One-year pediatric oncology grants for projects ready to overcome barriers to clinical translation—prioritizing immunotherapy/targeted therapy, high-grade brain tumors, and epigenetic or gene therapy; novel tech (omics, AI, gene editing, nanotech) welcomed.
Eligibility Criteria:
-
Children’s Oncology Group member institutions in North America; PIs at any academic rank (MD and/or PhD).
-
One application per institution total (either Individual or Collaborative) with Division Chief endorsement(s).
Funding Details:
-
Individual: USD 150,000 for 1 year (1–2 awards). Collaborative: up to USD 300,000 for 1 year (≥2 sites).
-
Up to 10% indirects; NIH salary cap applies; second-year renewal possible with full review. Correlative studies tied to funded trials considered.
Deadline:
-
Applications due September 15, 2025 (11:59 p.m.); awards announced late 2025; grant term Jan 1–Dec 31, 2026.
Where to Go for Further Information:
-
Submit via ProposalCentral; include 4-page project proposal, NIH biosketches, budget/justification, letters of support, and required assurances.
-
Questions: [email protected]; [email protected].